Sanofi and GSK COVID-19 vaccine candidate demonstrated strong immune responses across all adult age groups in Phase 2 trial
On May 17, 2021, Sanofi and GSK reported that their adjuvanted recombinant COVID-19 vaccine candidate achieved strong rates…
Oxford University and Oracle Partner to speed identification of COVID-19 variants
On May 17, 2021, Oxford University and Oracle have created a Global Pathogen Analysis System (GPAS) combining Oxfordﾒs…
Preliminary data suggested mixing Covid-19 vaccine increases reactogenicity
On May 13, 2021, University of Oxford researchers reported that Com-COV study data comparing mixed dosing schedules of…
Brain computer interface turned mental handwriting into text on screen
On May 12, 2021, HHMI researchers have, for the first time, decoded the neural signals associated with writing…
INOVIO’s Pan-COVID-19 vaccine candidate (INO-4802) induces broad immunity against vviral variants in preclinical studies
On May 12, 2021, Inovio Pharma announced that its next-generation Pan-COVID-19 vaccine candidate, INO-4802, induced potent neutralizing antibodies…
Dr. Connie Eaves was inducted into The Royal Society for her development of robust functional methods to quantify and characterize distinct types of primitive blood and mammary cell precursors.
On May 11, 2011, University of British Columbia professor Connie Eaves was inducted into The Royal Society for…
Gene therapy restored immune function in children with rare immunodeficiency
On May 10, 2021, the National Institutes of Health reported that an investigational gene therapy can safely restore…
Altimmune announced preclinical data for AdCOVIDﾙ demonstrating sterilizing immunity after single intranasal dose
On May 10, 2021, Altimmune announced positive results from a preclinical study of AdCOVID in a SARS-CoV-2 challenge…
FDA granted Fast Track Designation to CERC-002 for treatment of hospitalized patients with COVID-19
On May 10, 2021, Cerecor announced that the U.S. Food and Drug Administration (FDA) had granted Fast Track…
Pfizer and BioNTech received first U.S. EUA of COVID-19 vaccine in adolescents
On May 10, 2021, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) had expanded…
GSK and Vir Biotechnology announced start of the EMA rolling review of VIR-7831 (sotrovimab) for early treatment of COVID-19
On May 7, 2021, GlaxoSmithKline and Vir Biotechnology announced that the European Medicines Agency (EMA) has started a…
Pfizer and BioNTech announced supplying COVID-19 vaccine for Olympic athletes at 2020 Tokyo games
On May 6, 2021, Pfizer announced the signing of a Memorandum of Understanding (MoU) with the International Olympic…
Trevena announced TRV027 selected by NIH-funded ACTIV initiative for COVID-19 trial
On May 6, 2021, Trevena announced that TRV027, the Companyﾒs novel AT1 receptor selective agonist, had been selected…
U.S. sent first flight of medical supplies to India for COVID-19 fight
On May 5, 2021, the United States sent its first flight loaded with oxygen cylinders and regulators, N95…
WHO and Germany launched new global hub for pandemic and epidemic intelligence
On May 5, 2021, the World Health Organization (WHO) and the Federal Republic of Germany announced a new…
Humanigen reported positive phase 3 results demonstrating Lenzilumabﾙ improved survival without mechanical ventilation with COVID-19
On May 5, 2021, Humanigen announced that results from the lenzilumab Phase 3 study in hospitalized COVID-19 patients…
HDT Bio, Gennova Biopharma announced volunteers dosed in phase I/II trials of COVID-19 RNA vaccine in India
On May 4, 2021, HDT Bio announced that its development partner in India, Gennova Biopharmaceuticals, had begun dosing…
Researchers wirelessly recorded human brain activity during normal life activities
On May 3, 2021, the National Institutes of Health announced that researchers wre able to wirelessly record the…
Eiger announced Peginterferon Lambda added to multi-center phase 3 TOGETHER COVID-19 study in Brazil
On May 3, 2021, Eiger BioPharmaceuticals announced announced that Peginterferon Lambda (Lambda) will be added to the ongoing,…
Data from Vaxart oral COVID-19 vaccine phase I study suggested broad cross-reactivity against Coronaviruses
On May 3, 2021, Vaxart announced that new data obtained from its Phase I COVID-19 trial added to…
FDA approved treatment for chronic kidney disease
On Apr. 30, 2021, the FDA approved AstraZeneca’s Farxiga (dapagliflozin) oral tablets to reduce the risk of kidney…
FDA revoked the EUA of the Battelle CCDS Critical Care Decontamination System
On Apr. 30, 2021, the FDA revoked the emergency use authorization (EUA) of the Battelle CCDS Critical Care…
Babyﾒs first poop predicted risk of developing allergies
On Apr. 29, 2021, researchers at the University of British Columbia announced a study published in Cell Reports…
HHMI announced project to read genomes of all 70,000 vertebrate species
On Apr. 28, 2021, HHMI investigator Erich Jarvis and dozens of colleagues announced they had launched an ambitious…
XPhyto pursued market access in Israel for its COVID-19 PCR Rapid Test
On Apr. 28, 2021, XPhyto announce that it has delivered 2,000 of its rapid 25-minute PCR tests (ﾓCovid-ID…
VBI Vaccines announced publication of Challenge Study Data of its eVLP vaccine candidate against COVID-19
On Apr. 28, 2021, VBI Vaccines announced that preclinical data of VBIﾒs enveloped virus-like particle (eVLP) vaccine candidate,…
Innovation Pharma surpassed 50 percent enrollment in phase 2 clinical trial of Brilacidin for COVID-19
On Apr. 28, 2021, Innovation Pharma announced that enrollment had surpassed 50 percent of the total targeted number…
Merck announced licensing agreements with Indian manufacturers to expand access to molnupiravir for treatment of COVID-19
On Apr. 27, 2021, Merck announced the company had entered into non-exclusive voluntary licensing agreements for molnupiravir with…
AIM ImmunoTech announced positive safety data in second cohort of phase 1 study Investigating intranasal administration of Ampligen as treatment for COVID-19
On Apr. 27, 2021, AIM ImmunoTech announced that it had completed dosing of Cohort 2 in a Phase…
Biotechnology | Cartoons - Original | CDC | COVID-19 | Diagnostics | Life Science History | Medicine | NIH | Non-Profit Research | Pharmaceutical | Therapeutics | U.S. Congress | USDA | Vaccine | WHO
COVID-19 science and reason
COVID-19 and it’s naysayers are attacking Science and Reason. The defenders must suffer the slings and arrows from…